The Patent Finder

Quinoline Derivatives for the Treatment of Inflammatory Diseases

Universite de Montpellier

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/EP2015/066458, filed Jul 17, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,435,370Quinoline Derivatives for the Treatment of Inflammatory Diseases
In force
 · High confidence
UsedRemaining
Abivax, Centre National de la Recherche Scientifique, Institut Curie and Universite de MontpellierIn forceHigh confidence
US 10,981,874Use of Quinoline Derivatives for the Treatment of Inflammatory Diseases
In force
 · High confidence
AbivaxIn forceHigh confidence
US 11,649,210Use of Quinoline Derivatives for the Treatment of Inflammatory Diseases
In force
 · Low confidence
AbivaxIn forceLow confidence
US 11,649,211Use of Quinoline Derivatives for the Treatment of Inflammatory Diseases
In force
 · Low confidence
AbivaxIn forceLow confidence
US 12,202,804In Vitro or Ex Vivo Methods for Screening a Quinoline Derivative
In force
 · High confidence
AbivaxIn forceHigh confidence
Application 18/973,608In Vitro or Ex Vivo Methods for Screening a Quinoline Derivative
Pending
Not granted
AbivaxPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Universite de Montpellier.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited